On April 20, 2026, President Trump signed an executive order aimed at promoting research on psychedelic treatments, a move that has been met with significant support from advocates in the health community.
Many believe that this initiative could unlock new therapeutic avenues for mental health treatment, sparking excitement about the potential benefits of psychedelics.
However, there are underlying worries regarding the influence of the White House in this sensitive area, with some experts cautioning that such involvement might politicize the field and compromise its scientific integrity.